We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Diagnostic System for Internal Organ Diseases

By HospiMedica staff writers
Posted on 22 Nov 2004
A new noninvasive system based on the neurologic-reflexologic connection between internal organs and specific zones on the skin is designed to diagnose internal organ diseases, such as cardiovascular, endocrine, immune system, and digestive system diseases.

A trial of the system is now being planned at the Gastroenterology and Liver Diseases Institute at Surasky Medical Center (Tel Aviv, Israel) that will involve 310 patients suffering from a variety of liver diseases in various stages, in order to examine the possibilities for early detection of the disease as well as to monitor treatment. More...
The system was developed by Medex Screen Ltd. (Arad, Israel), founded by Dr. Alexander Kanevsky.

"The screening will be conducted as a blind study,” explained Dr. Kanevsky. "As part of the trial, diabetes patients will also be examined to check the possibility of a connection and influence between systemic diseases and liver damage.”

The MedexTest is painless and free of radiation. The neurologic connection between internal organs and zones on the skin is expressed in the interaction between changes in electrical resistance and conductivity of the skin, and changes in the functioning of internal organs. These data are fed into the MedexTest system, which processes and analyzes the changes, and translates the analyzed data into visual information displayed on the system's screen. With a medical analysis of the chart, a doctor can suggest a diagnosis with up to 90% precision, its severity, and whether it is chronic or temporary. The entire process takes only 20 minutes, and is conducted through touches with a pen-like sensor on the patient's palm and foot.

MedexTest has received the CE Mark as a screening device for the early-stage diagnostics of internal organ disorders. The system has also been approved for use by the Israeli Ministry of Health.


Related Links:
Medex Screen

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Portable Jaundice Management Device
Nymphaea
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.